Target organ damage: use of pulse wave analysis as a manifestation of aortic degeneration in the assessment of hypertension

Hyman DJ , Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-486.

Chobanian AV. Control of hypertension - an important national priority [Editorial]. N Engl J Med 2001; 345: 534-535.

Vasan RS , Larson MG , Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.

Panza JA. High-normal blood pressure - more ‘high’ than ‘normal’ [Editorial]. N Engl J Med 2001; 345: 1337-1340.

1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension . Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2447.

Staessen JA , Wang JG , Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-1315.

Nichols WW , O’Rourke MF (eds). McDonald’s blood flow in arteries, 4th edition. London: Arnold, 1997.

O’Rourke MF , Gallagher DE. Pulse wave analysis. J Hypertens 1996; 14 (suppl 5): S147-S157.

O’Rourke MF. Vascular mechanisms in the clinic. J Biomech 2002 (in press).

Messerli F , Ventura H , Amodeo C. Osler’s maneuver and pseudohypertension. N Engl J Med 1985; 13: 1548-1551.

Blacher J , Asmar R , Djane S , London G , Safar M. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.

Blacher J , Guerin A , Pannier B , Marchais S , Safar M , London G. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.

London GM , Blacher J , Pannier B , Guerin AP , Marchais SJ , Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438.

Saba PS , Roman MJ , Pini R et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22: 1873-1880.

Asmar RG , London GM , O’Rourke MF , Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001; 38: 922-926.

Bright R. Reports of medical cases selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy. London: Longmans, 1827.

Broadbent WH. The pulse: its diagnostic, prognostic and therapeutic indications. Lancet 1875; ii: 441-443, 549-550, 583-585, 901-907.

Marey EJ. Physiologie medicale de la circulation du sang. Paris: Adrien Dellahaye, 1863.

O’Rourke MF. Frederick Akbar Mahomed: historical perspective. Hypertension 1992; 19: 212-217.

Mackenzie J. The study of the pulse: arterial, venous and hepatic, and of the movements of the heart. Edinburgh: Young J Pent-land, 1902.

Osler W. The principles and practice of medicine, 3rd edition. Edinburgh: Young J Pentland, 1898.

Postel-Vinay N. A century of arterial hypertension 1896-1996. Chichester: Wiley, 1996.

O’Rourke MF , Vlachopoulos C , Graham R. Spurious systolic hyper-tension in youth. Vasc Med 2000; 5: 141-145.

Mahmud A , Feely J. Pseudo-systolic hypertension in young men - elastic not stiff arteries. J Hypertens 2001; (suppl 2): S115-S115.

Franklin SS , Khan SA , Wong ND , Larson MG , Levy D. The relation of blood pressure to coronary heart disease risk as a function of age: the Framingham Heart Study. J Am Coll Cardiol 2000; 35: 291A-291A.

Safar ME , London GM , for the Clinical Committee of Arterial Structure and Function , on behalf of the Working Group on Vascular Structure and Function of the European Society of Hypertension . Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. J Hypertens 2000; 18: 1527-1535.

Safar ME. Epidemiological findings imply that goals for drug treatment of hypertension need to be revised [Editorial]. Circulation 2001; 103: 1188-1189.